Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Vladimirov (St Petersburg, Russian Federation), A. Starshinova (ST PETERSBURG, Russian Federation). Thoracic surgery may improve outcome for bilateral cavitary multidrug- and extensively drug-resistant TB. 4858

Member's Comments

No comment yet.

Related content which might interest you: Consecutive surgical treatment for bilateral fibro-cavernous pulmonary TB Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015 Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis Source: Eur Respir J 2009; 34: 180-183 Year: 2009 The efficiency of surgical treatment for multidrug-resistant pulmonary and pleural tuberculosis Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 Treatment outcomes for XDR TB patients with surgery Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 The role of extrapleural thoracomyoplasty for conversion of smears in patients with drug resistant destructive pulmonary tuberculosis Source: International Congress 2014 – Infection, thoracic trauma and congenital lesions Year: 2014 Application of therapeutic pneumoperitoneum for multi-drug resistant cavitary TB in HIV – infected patients Source: Eur Respir J 2004; 24: Suppl. 48, 650s Year: 2004 Surgical approach to multidrug-resistant pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 323s Year: 2003 Safety aspects of endobronchial valve application in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions Year: 2012 Effectiveness of thoracoplasty at disseminated drug-resistant fibrous-cavernous pulmonary tuberculosis Source: Annual Congress 2010 - Special treatment options in tuberculosis Year: 2010 Clinical outcomes of patients with drug-resistant and extensively drug-resistant tuberculosis in Europe Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET) Year: 2008 Role thoracoplasty in surgical treatment patients with MDR lung tuberculosis Source: Annual Congress 2008 - Surgical treatment of lung tuberculosis Year: 2008 Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis Source: Eur Respir J 2006; 28: 576-580 Year: 2006 Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB Source: Eur Respir J 2009; 33: 1085-1094 Year: 2009 Application of thoracoplasty in the treatment of multi-drug resistant fibro-cavernous TB in prisoners Source: Eur Respir J 2003; 22: Suppl. 45, 525s Year: 2003 Surgical treatment of patients with disseminated destructive multidrug resistant lung tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 489s Year: 2005 Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis Source: Eur Respir J 2013; 41: 1393-1400 Year: 2013 Local artificial atelectasis in treatment of end-stage XDR cavitary tuberculosis Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009 Surgical and clinical assessment of pulmonary aspergillosis secondary to sequelar TB cavities Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement Year: 2008 A randomized study of the bronchoscopic valve blockade of the affected part of the lung in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis with treatment failure Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Surgical approach to multiresistant cavitary mycobacteriosis: indications and results of surgical management Source: Annual Congress 2004 - PG11 - Multiresistant tuberculosis and atypical mycobacterial disease Year: 2004